For citation:
. EUROPEAN MEDICINES AGENCY APPROVED APIXABAN USE IN CARDIOVERSION. Rational Pharmacotherapy in Cardiology. 2014;10(3):360. (In Russ.)
Views: 92
Fullscreen
Popular articles
Vol 11, No 3 (2015)
Vol 12, No 1 (2016)
Vol 5, No 1 (2009)
EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
Vol 3, No 5 (2007)
Vol 3, No 5 (2007)
Article Tools
Email this article (Login required)
Email the author (Login required)
Email this article (Login required)
Email the author (Login required)
About the Author
Keywords
acute coronary syndrome
amlodipine
antihypertensive therapy
apixaban
arterial hypertension
atherosclerosis
atrial fibrillation
beta-blockers
cardiovascular diseases
chronic heart failure
hypertension
ischemic heart disease
lisinopril
metabolic syndrome
myocardial infarction
obesity
risk factors
rivaroxaban
statins
stroke
warfarin
Moscow 101990, Russia
Petroverigsky per. 10
Tel.: +7 (499) 553 68 10
е-mail: otsec@sticom.ru
